Crossmark

Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic

Crossref DOI link: https://doi.org/10.1007/s10103-022-03580-6

Published Online: 2022-05-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Yuchen https://orcid.org/0000-0002-4576-8924
Dennis, Simon C.

Brewin, Mark P. https://orcid.org/0000-0002-4456-5885
License Information

Text and Data Mining valid from 2022-05-30

Version of Record valid from 2022-05-30
More Information

Article History

Received: 8 March 2022

Accepted: 24 May 2022

First Online: 30 May 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below